Vigonvita Life Sciences Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	May '26 May 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	11,740	13,718	-	-
Enterprise Value	11,872	14,171	-	-
Last Close Price	70.05	81.85	-	-
PS Ratio	103.33	120.74	-	-
PB Ratio	24.21	28.29	-	-
P/TBV Ratio	27.87	32.57	-	-
EV/Sales Ratio	104.49	124.73	-	-
Debt / Equity Ratio	1.48	1.48	3.05	1.71
Debt / EBITDA Ratio	-	-	-	13.34
Net Debt / Equity Ratio	0.30	0.30	2.18	1.20
Net Debt / EBITDA Ratio	-0.41	-0.41	-1.67	15.93
Net Debt / FCF Ratio	-0.50	-0.50	-1.64	-4.01
Asset Turnover	0.10	0.10	0.02	-
Inventory Turnover	2.60	2.60	1.11	-
Quick Ratio	1.05	1.05	0.46	0.56
Current Ratio	1.07	1.07	0.50	0.58
Return on Equity (ROE)	-123.98%	-123.98%	-132.51%	-
Return on Assets (ROA)	-20.73%	-20.73%	-18.15%	-
Return on Capital Employed (ROCE)	-43.70%	-43.70%	-50.40%	1.90%
Earnings Yield	-3.37%	-2.89%	-	-
FCF Yield	-2.43%	-2.08%	-	-
Buyback Yield / Dilution	-	-4.87%	-0.69%	-